What Are mRNA Therapies, And How Are They Used For Vaccines?
On a clairement un saut de technologie qui rebat les cartes en < 1an .. des labos qui obtiennent de super résultats 90% pour la COVID quand la technologie "minitel" reste à 60% … c'est ouf !
Prior to the Covid-19 pandemic, mRNA vaccines and therapeutics were estimated to reach a market size over $6B by 2025, per CB Insights’ industry analyst consensus.
There are currently 520+ ongoing clinical trials testing mRNA across more than 20 disease categories.
Certain obstacles remain for commercializing mRNA therapies. For example, mRNA-based therapies are temperature sensitive (the Pfizer/Bi’oNTech vaccine must be kept at -70° Celsius, while the Moderna vaccine requires -20°). Developing a robust pharmaceutical cold chain will be a critical component to widespread mRNA therapeutic adoption.
Usecases:
- mRNA vaccines for infectious diseases
- Therapies for rare genetic diseases
- Cancer immunotherapies
via CB Insights Research : lire l’article source